Centogene (CNTGF) has released an update.
Centogene N.V., a notable entity in the biotech industry, has recently transitioned its former CFO, Jose Miguel Coego Rios, to a consultancy role. Rios’s new agreement with the company, effective from October 1, 2024, will have him offering business consulting services until the end of December 2024. This strategic move indicates Centogene’s commitment to leveraging experienced executive guidance to steer its future endeavors.
For further insights into CNTGF stock, check out TipRanks’ Stock Analysis page.
